Clinical Research Informer

Medicaid, with planned payment pilot, girds for influx of pricey gene therapies

Bio Pharma Dive

FEBRUARY 21, 2023

The proposed model could help state Medicaid agencies explore different kinds of outcomes-based payment schemes, but may come too late to prepare for the first sickle cell gene therapy.

Gene Therapy

Gene Therapy Gene

Senators propose new Medicare program that would offer incentive payments to combat drug shortages

Fierce Pharma

MAY 8, 2024

Under the framework, hospitals, purchasers and generic drugmakers could earn incentive payments after meeting new contracting and purchasing standards. drug shortages run rampant, lawmakers are getting creative with their attempts to ease the situation.

Drugs

Drugs Manufacturing

Esperion in dispute with Daiichi over drug milestone payment

Bio Pharma Dive

MARCH 16, 2023

The companies disagree over what qualifies for a payment of up to $300 million that’s associated with inclusion of heart data on the cholesterol drug’s label.

Drugs

Key achievement for Repare Therapeutics after receipt of $40 million Roche payment

Outsourcing Pharma

JANUARY 29, 2024

has received a $40 million milestone payment from Roche after dosing the first patient in a clinical trial. Clinical-stage precision oncology company, Repare Therapeutics Inc.,

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Development

New CMS pilot to test payment scheme for pricey sickle cell gene therapies

Bio Pharma Dive

JANUARY 31, 2024

The agency is planning a pilot program across states to help sickle cell patients access treatments like the newly approved Casgevy and Lyfgenia.

Gene Therapy

Gene Therapy Gene

The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

Drug Patent Watch

AUGUST 5, 2023

In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies.

Amazon One Palm-Scanning Payment Expands to Whole Foods

XTalks

JULY 25, 2023

Amazon One, the revolutionary palm-scanning payment technology from Amazon, is set to expand significantly across the US. The payment system has also been making steady inroads into Whole Foods locations, ahead of this expansion announcement.

Marketing

STAT+: Hospitals win higher payments from Medicare after lobbying campaign

STAT News

AUGUST 1, 2022

Hospitals secured significantly larger payments from Medicare for 2023, after months of lobbying centered around arguments that inflation and the pandemic have crippled hospitals’ finances.

Marketing

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license

Fierce Pharma

FEBRUARY 24, 2023

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18

Licensing

Licensing Licensing Vaccination Vaccine

7 Benefits of Digitizing Clinical Trial Budgets & Payments Management

Cloudbyz

MARCH 1, 2023

Conducting clinical trials requires significant investments of time and resources, including the management of budgets and payments. Historically, the management of budgets and payments in clinical trials has been a paper-based process. Following are the benefits of digitizing clinical trials budgets and payments.

Clinical Trials

Clinical Trials Clinical Trials Trials Compliance

STAT+: Physicians rally to avert Medicare payment cuts

STAT News

NOVEMBER 2, 2022

The federal government is officially reducing Medicare payments to physicians next year by 4.5%, but doctors and their lobbyists are ready to blitz Congress over the next two months to convince lawmakers that those cuts should be averted — again.

Doctors

Doctors Doctor Regulation

Opinion: Value-based payment has produced little value. It needs a time-out

STAT News

JULY 26, 2022

The value-based payment crusade is now two decades old. It is time for proponents of value-based care to call a halt to these programs until they have an answer to this question: “Why have the vast majority of value-based payment experiments failed to improve value?

Opinion: How value-based payments to clinicians can help close equity gaps

STAT News

DECEMBER 28, 2022

Until recently, though, value-based payment models have not explicitly addressed longstanding racial and ethnic inequities in care. health system has been evolving over the past decade to focus on the quality and value of care.

UK launches its ‘Netflix-style’ payment model for antibiotics

pharmaphorum

APRIL 12, 2022

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. ” The post UK launches its ‘Netflix-style’ payment model for antibiotics appeared first on.

Pharma Companies

Pharma Companies Development Drugs Medicine

Esperion-Daiichi Sankyo Partnership Saga Continues with Payment Spat

BioSpace

MARCH 16, 2023

Esperion-Daiichi Sankyo Partnership Saga Continues with Payment Spat 3/17/2023

Pfizer adjusts EU vaccine deal but still wants payment for undelivered doses: FT

Fierce Pharma

MARCH 15, 2023

Pfizer adjusts EU vaccine deal but still wants payment for undelivered doses: FT esagonowsky Wed, 03/15/2023 - 08:43

Vaccination

Vaccination Vaccine

Esperion and Daiichi Sankyo bump heads on Nexletol milestone payments

Fierce Pharma

MARCH 16, 2023

Esperion and Daiichi Sankyo bump heads on Nexletol milestone payments zbecker Thu, 03/16/2023 - 11:46

STAT+: A new Medicare ruling could give virtual reality companies an easier path to payment

STAT News

MARCH 21, 2023

The path to payment for virtual reality companies working in health care just became slightly smoother. AppliedVR, a company targeting chronic pain, has become the first digital therapeutic to find an easy way to secure reimbursement from the Centers for Medicare and Medicaid Services.

Production

Production Drugs

Visibility of Payments for Sites: Enhancing Transparency and Streamlining the Process

Cloudbyz

MAY 4, 2023

Financial transparency and timely payments are critical to maintaining strong relationships with clinical sites and ensuring their continued participation in trials. However, the visibility of payments for sites can often be limited due to complex invoicing processes and contractual agreements.

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Research

Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit

Fierce Pharma

MARCH 28, 2023

Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit zbecker Tue, 03/28/2023 - 11:09

Study links child tax credit payments to reduced child abuse, neglect

Medical Xpress

FEBRUARY 17, 2023

Now, a new study led by School of Public Policy Assistant Professor Lindsey Rose Bullinger shows the expansion's monthly payments also helped reduce child abuse and neglect—at least temporarily.

Research

What Manufacturers Need to Know About Alternative Payment Models

Drug Channels

JULY 15, 2022

Carolyn explains the advantages of alternative payment models (APM) for measuring and rewarding value and outcomes in our healthcare system. Today’s guest post comes from Carolyn Zele, Senior Manager of Solution Enablement at MMIT. For more on how APMs measure value, click here to learn about MMIT’s Pulse Analytics Solution.

Manufacturing

Manufacturing Drugs

STAT+: HHS will decide how to resolve $1 billion in payments for 340B hospitals

STAT News

JANUARY 10, 2023

The decision is the latest installment in a legal dispute between hospitals that get discounted drugs through the 340B program and the federal government over Medicare payment formulas. The repayments HHS owes hospitals total more than $1 billion, and hospitals had hoped the court would force the government to pay them back immediately.

Drugs

Opinion: Keep equity in mind when moving to value-based payment

STAT News

JULY 19, 2022

As this type of payment reform expands, implementing the necessary changes to enable it must operate from a frame of equity rather than equality. Value-based care champions health and justice by focusing on outcomes rather than on units of service.

UK pharma industry hits out at plans to rework statutory payment scheme

Pharmaceutical Technology

OCTOBER 9, 2023

More than 20 pharmaceutical companies across the UK have hit out against a proposed measure in the UK's regulation of medicines.

Regulation

Regulation Medicine

More Than a Feeling: Five Key Challenges When Walking Away From Commercial/340B Duplicate Payments

Drug Channels

SEPTEMBER 29, 2023

Micah outlines why it's more than a feeling that manufacturers struggle to walk away from these duplicate payments. According to Kalderos, at least 5% of commercial rebates are paid for prescriptions that also have discounts under the 340B Drug Pricing Program.

Manufacturing

Manufacturing Drugs

Royalty Pharma pays startup $525M for stake in Sanofi MS drug

Bio Pharma Dive

MAY 9, 2024

The deal gives the company milestone payments and royalties to a medicine, frexalimab, that Sanofi licensed from biotech ImmuNext and expects to be a future blockbuster.

Licensing

Licensing Licensing Medicine Drugs

Mithra unlocks €1.25m from Fuji Pharma in Estelle licence payment

Pharmaceutical Technology

AUGUST 3, 2023

Mithra has received €1.25m ($1.37m) from Fuji Pharma as part of a 2016 licence agreement involving Estelle for Japan and ASEAN regions.

A Reuters Pharma conversation with EY: smart reviewing and payment outcomes

pharmaphorum

NOVEMBER 23, 2022

Within EY, I work a lot more on our innovative offerings around market access, so we are really striving to move the industry and healthcare system forward – payment for performance, outcome performance.”. More recently, Alice has been particularly focused on how to change the pricing landscape to move towards payment on outcomes.

Life Science

Life Science Marketing Medicine Production

Pfizer takes Poland to court over alleged missed COVID-19 vaccine payments

Fierce Pharma

NOVEMBER 28, 2023

As the pandemic eased earlier this year, officials in Poland became vocal critics of the financial obligations laid down by Pfizer’s large vaccine supply pact with the European Union. |

Vaccination

Vaccination Vaccine

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

Pharmaceutical Technology

MAY 13, 2024

Takeda will pay $100m upfront and up to $2.1bn in milestone-based payments for licencing AC immune’s amyloid beta-targeting immunotherapy.

Licensing

Licensing Licensing

Critical care medicine organizations urge House leadership to stop Medicare payment cuts

Medical Xpress

DECEMBER 15, 2022

Today, the American Society of Anesthesiologists (ASA), Society of Critical Care Anesthesiologists (SOCCA), and Society of Critical Care Medicine (SCCM) sent a formal communication to Speaker of the House of Representatives Nancy Pelosi, House Majority Leader Charles Schumer, and House Minority leaders Kevin McCarthy and Mitch McConnell, strongly urging (..)

Medicine

10 Reasons Why Your Site Needs a CTMS and Payments Solution for Clinical Trials

Cloudbyz

APRIL 16, 2023

Clinical Trial Management Systems (CTMS) and payments solutions are software platforms designed to streamline the management and administration of clinical trials. In this blog, we will discuss the top five reasons why a site should use a CTMS and payments solution.

Clinical Trials

Clinical Trials Clinical Trials Trials Compliance

Court reverses Servier verdict on Mediator, ?orders payment of €430M

Fierce Pharma

DECEMBER 21, 2023

Two years ago, with a favorable ruling and a slap-on-the | A favorable ruling two years ago had Servier hoping that its decades-long litigation surrounding weight-loss pill Mediator was finally over. But an appeal from prosecutors now leaves the company facing a hefty penalty.

Assentia launches tech platforms to support payments in the clinical trial space

Outsourcing Pharma

MARCH 14, 2023

The company releases two SaaS-based applications, GrantPay and GrantPact, to provide clinical trial contract negotiation and payment services.

Clinical Trials

Clinical Trials Clinical Trials Trials Contract Manufacturing

Patient Retention Insights: Use Payments to Enrich Diversity, DCTs Need Special Attention

ACRP blog

FEBRUARY 15, 2023

A key focus in the clinical trial diversity plans that are part of this year’s omnibus spending bill signed by President Biden should be participant payments and reimbursement, writes Kelly FitzGerald, PhD, IRB Executive Chair and Vice President for IBC Affairs at WCG IRB.

Clinical Trials

Clinical Trials Clinical Trials Clinical Research Trials

Cidara gains first FDA approval, $20M milestone payment as FDA endorses Rezzayo

Fierce Pharma

MARCH 23, 2023

Cidara gains first FDA approval, $20M milestone payment as FDA endorses Rezzayo kdunleavy Thu, 03/23/2023 - 10:51

FDA Approval

Moderna may seek to claw back payments to ex-CFO

Bio Pharma Dive

MAY 17, 2022

Jorge Gomez, who lasted one day on the job before being ousted over an investigation at his former company, is owed $700,000 — money Moderna says it can recoup if wrongdoing is proven.

After row with Hungary and Poland, Pfizer sues Romania over missed COVID vaccine payments

Fierce Pharma

JANUARY 19, 2024

Following public spats with Hungary and Poland, Pfizer and its German mRNA partner BioNTech have kicked off legal proceedings against Romania. Following public spats with Hungary and Poland, Pfizer and its German mRNA partner BioNTech have kicked off legal proceedings against Romania.

Vaccination

Vaccination Vaccine

Industry Payments Consistently Linked to Physician Prescribing

The Pharma Data

DECEMBER 1, 2020

Industry Payments Consistently Linked to Physician Prescribing. 1, 2020 — Industry payments are associated with physician prescribing patterns, according to a systematic review published online Nov. “The medical community must change its historical opposition to reform and call for an end to such payments.”

Branding

Branding Drugs Medicine Research

The Incompatibility of Patient-Centered Care With Fee-For-Service Payment

JAMA Internal Medicine

SEPTEMBER 27, 2020

This essay details the services provided by primary care clinicians that are not covered by fee-for-service payments but that are more important to patients, especially near the end of life, than many expensive, unwanted tests for which fee-for-service payments are available.

Genmab Seeks $405M from Janssen in Arbitration Over Royalty Payments

BioSpace

JUNE 9, 2022

Genmab A/S is seeking a new arbitration ruling against Janssen seeking $405 million-plus interest in accrued milestone payments for Darzalex Faspro.

Relay Therapeutics Snaps up ZebiAI with $85 Million Upfront Payment

BioSpace

APRIL 15, 2021

based ZebiAI with an $85 million upfront payment. In an effort to boost drug discovery for the “toughest drug discovery problems” through the use of machine learning, precision medicines company Relay Therapeutics is acquiring Waltham, Mass.-based

Medicine

Medicine Drugs

Vicore licenses idiopathic pulmonary fibrosis therapy to Nippon in Japan

Pharmaceutical Technology

FEBRUARY 9, 2024

Nippon will pay $10m upfront and up to $275m in milestone-based payments for the developmental and commercial rights to Vicore’s C21 in Japan.

Licensing

Licensing Licensing

Medicaid, with planned payment pilot, girds for influx of pricey gene therapies

Senators propose new Medicare program that would offer incentive payments to combat drug shortages

Trending Sources

Esperion in dispute with Daiichi over drug milestone payment

Key achievement for Repare Therapeutics after receipt of $40 million Roche payment

New CMS pilot to test payment scheme for pricey sickle cell gene therapies

The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

Amazon One Palm-Scanning Payment Expands to Whole Foods

STAT+: Hospitals win higher payments from Medicare after lobbying campaign

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license

7 Benefits of Digitizing Clinical Trial Budgets & Payments Management

STAT+: Physicians rally to avert Medicare payment cuts

Opinion: Value-based payment has produced little value. It needs a time-out

Opinion: How value-based payments to clinicians can help close equity gaps

UK launches its ‘Netflix-style’ payment model for antibiotics

Esperion-Daiichi Sankyo Partnership Saga Continues with Payment Spat

Pfizer adjusts EU vaccine deal but still wants payment for undelivered doses: FT

Esperion and Daiichi Sankyo bump heads on Nexletol milestone payments

STAT+: A new Medicare ruling could give virtual reality companies an easier path to payment

Visibility of Payments for Sites: Enhancing Transparency and Streamlining the Process

Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit

Study links child tax credit payments to reduced child abuse, neglect

What Manufacturers Need to Know About Alternative Payment Models

STAT+: HHS will decide how to resolve $1 billion in payments for 340B hospitals

Opinion: Keep equity in mind when moving to value-based payment

UK pharma industry hits out at plans to rework statutory payment scheme

More Than a Feeling: Five Key Challenges When Walking Away From Commercial/340B Duplicate Payments

Royalty Pharma pays startup $525M for stake in Sanofi MS drug

Mithra unlocks €1.25m from Fuji Pharma in Estelle licence payment

A Reuters Pharma conversation with EY: smart reviewing and payment outcomes

Pfizer takes Poland to court over alleged missed COVID-19 vaccine payments

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

Critical care medicine organizations urge House leadership to stop Medicare payment cuts

10 Reasons Why Your Site Needs a CTMS and Payments Solution for Clinical Trials

Court reverses Servier verdict on Mediator, ?orders payment of €430M

Assentia launches tech platforms to support payments in the clinical trial space

Patient Retention Insights: Use Payments to Enrich Diversity, DCTs Need Special Attention

Cidara gains first FDA approval, $20M milestone payment as FDA endorses Rezzayo

Moderna may seek to claw back payments to ex-CFO

After row with Hungary and Poland, Pfizer sues Romania over missed COVID vaccine payments

Industry Payments Consistently Linked to Physician Prescribing

The Incompatibility of Patient-Centered Care With Fee-For-Service Payment

Genmab Seeks $405M from Janssen in Arbitration Over Royalty Payments

Relay Therapeutics Snaps up ZebiAI with $85 Million Upfront Payment

Vicore licenses idiopathic pulmonary fibrosis therapy to Nippon in Japan

Stay Connected